Covered recipient · General Payments record
M MATTHEW AHRANJANI
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2022
$1,994.81
- Reported across 78 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $308.23 | 19 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $178.71 | 13 |
| PFIZER INC. | $99.34 | 4 |
| Minerva Surgical, Inc | $18.44 | 1 |
| Merck Sharp & Dohme Corporation | $11.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.74 | 02/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944516519 | CMS |
| Minerva Surgical, Inc | $18.44 | 03/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 894325875 | CMS |
| Novo Nordisk Inc | $1.05 | 01/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 905973747 | CMS |
| Novo Nordisk Inc | $9.60 | 01/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 905973749 | CMS |
| Novo Nordisk Inc | $19.48 | 02/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 905973745 | CMS |
| Novo Nordisk Inc | $0.63 | 02/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 905973765 | CMS |
| Novo Nordisk Inc | $21.29 | 03/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 905973751 | CMS |
| Novo Nordisk Inc | $20.95 | 05/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 905973757 | CMS |
| Novo Nordisk Inc | $21.86 | 06/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 905973761 | CMS |
| Novo Nordisk Inc | $0.69 | 06/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 905973755 | CMS |
| Novo Nordisk Inc | $0.67 | 07/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 905973753 | CMS |
| Novo Nordisk Inc | $17.83 | 07/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 905973763 | CMS |
| Novo Nordisk Inc | $18.97 | 08/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 902921045 | CMS |
| Novo Nordisk Inc | $23.19 | 09/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 902927163 | CMS |
| Novo Nordisk Inc | $22.50 | 10/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 905973759 | CMS |
| PFIZER INC. | $25.81 | 03/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949126245 | CMS |
| PFIZER INC. | $25.07 | 05/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949158139 | CMS |
| PFIZER INC. | $27.90 | 07/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949244119 | CMS |
| PFIZER INC. | $20.56 | 11/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949550525 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.